0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Collagen Medical Aesthetic Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-8I15634
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Collagen Medical Aesthetic Injection Market Research Report 2023
BUY CHAPTERS

Global Recombinant Collagen Medical Aesthetic Injection Market Research Report 2025

Code: QYRE-Auto-8I15634
Report
May 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Recombinant Collagen Medical Aesthetic Injection Market

The global market for Recombinant Collagen Medical Aesthetic Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Recombinant Collagen Medical Aesthetic Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Collagen Medical Aesthetic Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Recombinant Collagen Medical Aesthetic Injection include Nasvita Medical, Mei Medica, Hyamax, Allergan Aesthetics, CollPlant, Giant Biogene Holding Co., Ltd, Jinbo Bio, Shuangmei Biotechnology Co., Ltd, Bloomage Bio, Changchun Botai Pharmaceutical Biotechnology Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Collagen Medical Aesthetic Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Collagen Medical Aesthetic Injection.
The Recombinant Collagen Medical Aesthetic Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Collagen Medical Aesthetic Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Collagen Medical Aesthetic Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Collagen Medical Aesthetic Injection Market Report

Report Metric Details
Report Name Recombinant Collagen Medical Aesthetic Injection Market
Segment by Type
  • Plant-derived Collagen
  • Animal-derived Collagen
Segment by Application
  • Hospital
  • Beauty Agency
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Nasvita Medical, Mei Medica, Hyamax, Allergan Aesthetics, CollPlant, Giant Biogene Holding Co., Ltd, Jinbo Bio, Shuangmei Biotechnology Co., Ltd, Bloomage Bio, Changchun Botai Pharmaceutical Biotechnology Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Collagen Medical Aesthetic Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Collagen Medical Aesthetic Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant Collagen Medical Aesthetic Injection Market report?

Ans: The main players in the Recombinant Collagen Medical Aesthetic Injection Market are Nasvita Medical, Mei Medica, Hyamax, Allergan Aesthetics, CollPlant, Giant Biogene Holding Co., Ltd, Jinbo Bio, Shuangmei Biotechnology Co., Ltd, Bloomage Bio, Changchun Botai Pharmaceutical Biotechnology Co., Ltd.

What are the Application segmentation covered in the Recombinant Collagen Medical Aesthetic Injection Market report?

Ans: The Applications covered in the Recombinant Collagen Medical Aesthetic Injection Market report are Hospital, Beauty Agency

What are the Type segmentation covered in the Recombinant Collagen Medical Aesthetic Injection Market report?

Ans: The Types covered in the Recombinant Collagen Medical Aesthetic Injection Market report are Plant-derived Collagen, Animal-derived Collagen

Recommended Reports

Collagen-Based Aesthetics

Medical Aesthetic Devices

Injectables & Treatments

1 Recombinant Collagen Medical Aesthetic Injection Market Overview
1.1 Product Definition
1.2 Recombinant Collagen Medical Aesthetic Injection by Type
1.2.1 Global Recombinant Collagen Medical Aesthetic Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Plant-derived Collagen
1.2.3 Animal-derived Collagen
1.3 Recombinant Collagen Medical Aesthetic Injection by Application
1.3.1 Global Recombinant Collagen Medical Aesthetic Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Beauty Agency
1.4 Global Recombinant Collagen Medical Aesthetic Injection Market Size Estimates and Forecasts
1.4.1 Global Recombinant Collagen Medical Aesthetic Injection Revenue 2020-2031
1.4.2 Global Recombinant Collagen Medical Aesthetic Injection Sales 2020-2031
1.4.3 Global Recombinant Collagen Medical Aesthetic Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Collagen Medical Aesthetic Injection Market Competition by Manufacturers
2.1 Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Collagen Medical Aesthetic Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Collagen Medical Aesthetic Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Collagen Medical Aesthetic Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Collagen Medical Aesthetic Injection, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Collagen Medical Aesthetic Injection, Date of Enter into This Industry
2.8 Global Recombinant Collagen Medical Aesthetic Injection Market Competitive Situation and Trends
2.8.1 Global Recombinant Collagen Medical Aesthetic Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Collagen Medical Aesthetic Injection Players Market Share by Revenue
2.8.3 Global Recombinant Collagen Medical Aesthetic Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Collagen Medical Aesthetic Injection Market Scenario by Region
3.1 Global Recombinant Collagen Medical Aesthetic Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Collagen Medical Aesthetic Injection Sales by Region: 2020-2031
3.2.1 Global Recombinant Collagen Medical Aesthetic Injection Sales by Region: 2020-2025
3.2.2 Global Recombinant Collagen Medical Aesthetic Injection Sales by Region: 2026-2031
3.3 Global Recombinant Collagen Medical Aesthetic Injection Revenue by Region: 2020-2031
3.3.1 Global Recombinant Collagen Medical Aesthetic Injection Revenue by Region: 2020-2025
3.3.2 Global Recombinant Collagen Medical Aesthetic Injection Revenue by Region: 2026-2031
3.4 North America Recombinant Collagen Medical Aesthetic Injection Market Facts & Figures by Country
3.4.1 North America Recombinant Collagen Medical Aesthetic Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Collagen Medical Aesthetic Injection Sales by Country (2020-2031)
3.4.3 North America Recombinant Collagen Medical Aesthetic Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Collagen Medical Aesthetic Injection Market Facts & Figures by Country
3.5.1 Europe Recombinant Collagen Medical Aesthetic Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Collagen Medical Aesthetic Injection Sales by Country (2020-2031)
3.5.3 Europe Recombinant Collagen Medical Aesthetic Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Collagen Medical Aesthetic Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Collagen Medical Aesthetic Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Collagen Medical Aesthetic Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Collagen Medical Aesthetic Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Collagen Medical Aesthetic Injection Market Facts & Figures by Country
3.7.1 Latin America Recombinant Collagen Medical Aesthetic Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Collagen Medical Aesthetic Injection Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Collagen Medical Aesthetic Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Collagen Medical Aesthetic Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Collagen Medical Aesthetic Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Collagen Medical Aesthetic Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Collagen Medical Aesthetic Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Collagen Medical Aesthetic Injection Sales by Type (2020-2031)
4.1.1 Global Recombinant Collagen Medical Aesthetic Injection Sales by Type (2020-2025)
4.1.2 Global Recombinant Collagen Medical Aesthetic Injection Sales by Type (2026-2031)
4.1.3 Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Collagen Medical Aesthetic Injection Revenue by Type (2020-2031)
4.2.1 Global Recombinant Collagen Medical Aesthetic Injection Revenue by Type (2020-2025)
4.2.2 Global Recombinant Collagen Medical Aesthetic Injection Revenue by Type (2026-2031)
4.2.3 Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Collagen Medical Aesthetic Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Collagen Medical Aesthetic Injection Sales by Application (2020-2031)
5.1.1 Global Recombinant Collagen Medical Aesthetic Injection Sales by Application (2020-2025)
5.1.2 Global Recombinant Collagen Medical Aesthetic Injection Sales by Application (2026-2031)
5.1.3 Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Collagen Medical Aesthetic Injection Revenue by Application (2020-2031)
5.2.1 Global Recombinant Collagen Medical Aesthetic Injection Revenue by Application (2020-2025)
5.2.2 Global Recombinant Collagen Medical Aesthetic Injection Revenue by Application (2026-2031)
5.2.3 Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Collagen Medical Aesthetic Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Nasvita Medical
6.1.1 Nasvita Medical Company Information
6.1.2 Nasvita Medical Description and Business Overview
6.1.3 Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Product Portfolio
6.1.5 Nasvita Medical Recent Developments/Updates
6.2 Mei Medica
6.2.1 Mei Medica Company Information
6.2.2 Mei Medica Description and Business Overview
6.2.3 Mei Medica Recombinant Collagen Medical Aesthetic Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mei Medica Recombinant Collagen Medical Aesthetic Injection Product Portfolio
6.2.5 Mei Medica Recent Developments/Updates
6.3 Hyamax
6.3.1 Hyamax Company Information
6.3.2 Hyamax Description and Business Overview
6.3.3 Hyamax Recombinant Collagen Medical Aesthetic Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hyamax Recombinant Collagen Medical Aesthetic Injection Product Portfolio
6.3.5 Hyamax Recent Developments/Updates
6.4 Allergan Aesthetics
6.4.1 Allergan Aesthetics Company Information
6.4.2 Allergan Aesthetics Description and Business Overview
6.4.3 Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Product Portfolio
6.4.5 Allergan Aesthetics Recent Developments/Updates
6.5 CollPlant
6.5.1 CollPlant Company Information
6.5.2 CollPlant Description and Business Overview
6.5.3 CollPlant Recombinant Collagen Medical Aesthetic Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CollPlant Recombinant Collagen Medical Aesthetic Injection Product Portfolio
6.5.5 CollPlant Recent Developments/Updates
6.6 Giant Biogene Holding Co., Ltd
6.6.1 Giant Biogene Holding Co., Ltd Company Information
6.6.2 Giant Biogene Holding Co., Ltd Description and Business Overview
6.6.3 Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product Portfolio
6.6.5 Giant Biogene Holding Co., Ltd Recent Developments/Updates
6.7 Jinbo Bio
6.7.1 Jinbo Bio Company Information
6.7.2 Jinbo Bio Description and Business Overview
6.7.3 Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Product Portfolio
6.7.5 Jinbo Bio Recent Developments/Updates
6.8 Shuangmei Biotechnology Co., Ltd
6.8.1 Shuangmei Biotechnology Co., Ltd Company Information
6.8.2 Shuangmei Biotechnology Co., Ltd Description and Business Overview
6.8.3 Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product Portfolio
6.8.5 Shuangmei Biotechnology Co., Ltd Recent Developments/Updates
6.9 Bloomage Bio
6.9.1 Bloomage Bio Company Information
6.9.2 Bloomage Bio Description and Business Overview
6.9.3 Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Product Portfolio
6.9.5 Bloomage Bio Recent Developments/Updates
6.10 Changchun Botai Pharmaceutical Biotechnology Co., Ltd.
6.10.1 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Company Information
6.10.2 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Description and Business Overview
6.10.3 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Product Portfolio
6.10.5 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Collagen Medical Aesthetic Injection Industry Chain Analysis
7.2 Recombinant Collagen Medical Aesthetic Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Collagen Medical Aesthetic Injection Production Mode & Process Analysis
7.4 Recombinant Collagen Medical Aesthetic Injection Sales and Marketing
7.4.1 Recombinant Collagen Medical Aesthetic Injection Sales Channels
7.4.2 Recombinant Collagen Medical Aesthetic Injection Distributors
7.5 Recombinant Collagen Medical Aesthetic Injection Customer Analysis
8 Recombinant Collagen Medical Aesthetic Injection Market Dynamics
8.1 Recombinant Collagen Medical Aesthetic Injection Industry Trends
8.2 Recombinant Collagen Medical Aesthetic Injection Market Drivers
8.3 Recombinant Collagen Medical Aesthetic Injection Market Challenges
8.4 Recombinant Collagen Medical Aesthetic Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Recombinant Collagen Medical Aesthetic Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Collagen Medical Aesthetic Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Collagen Medical Aesthetic Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Collagen Medical Aesthetic Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Collagen Medical Aesthetic Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Collagen Medical Aesthetic Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Collagen Medical Aesthetic Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Collagen Medical Aesthetic Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Collagen Medical Aesthetic Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Collagen Medical Aesthetic Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Collagen Medical Aesthetic Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Collagen Medical Aesthetic Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Collagen Medical Aesthetic Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Collagen Medical Aesthetic Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Collagen Medical Aesthetic Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Collagen Medical Aesthetic Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Collagen Medical Aesthetic Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Collagen Medical Aesthetic Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Collagen Medical Aesthetic Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Collagen Medical Aesthetic Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Collagen Medical Aesthetic Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Collagen Medical Aesthetic Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Collagen Medical Aesthetic Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Collagen Medical Aesthetic Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Collagen Medical Aesthetic Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Collagen Medical Aesthetic Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Collagen Medical Aesthetic Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Collagen Medical Aesthetic Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Collagen Medical Aesthetic Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Collagen Medical Aesthetic Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Collagen Medical Aesthetic Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Collagen Medical Aesthetic Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Collagen Medical Aesthetic Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Collagen Medical Aesthetic Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Collagen Medical Aesthetic Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Collagen Medical Aesthetic Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Collagen Medical Aesthetic Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Collagen Medical Aesthetic Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Collagen Medical Aesthetic Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Collagen Medical Aesthetic Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Collagen Medical Aesthetic Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Collagen Medical Aesthetic Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Collagen Medical Aesthetic Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Collagen Medical Aesthetic Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Collagen Medical Aesthetic Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Collagen Medical Aesthetic Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Collagen Medical Aesthetic Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Collagen Medical Aesthetic Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Collagen Medical Aesthetic Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Collagen Medical Aesthetic Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Collagen Medical Aesthetic Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Collagen Medical Aesthetic Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Collagen Medical Aesthetic Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Collagen Medical Aesthetic Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Collagen Medical Aesthetic Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Nasvita Medical Company Information
 Table 71. Nasvita Medical Description and Business Overview
 Table 72. Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Product
 Table 74. Nasvita Medical Recent Developments/Updates
 Table 75. Mei Medica Company Information
 Table 76. Mei Medica Description and Business Overview
 Table 77. Mei Medica Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Mei Medica Recombinant Collagen Medical Aesthetic Injection Product
 Table 79. Mei Medica Recent Developments/Updates
 Table 80. Hyamax Company Information
 Table 81. Hyamax Description and Business Overview
 Table 82. Hyamax Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hyamax Recombinant Collagen Medical Aesthetic Injection Product
 Table 84. Hyamax Recent Developments/Updates
 Table 85. Allergan Aesthetics Company Information
 Table 86. Allergan Aesthetics Description and Business Overview
 Table 87. Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Product
 Table 89. Allergan Aesthetics Recent Developments/Updates
 Table 90. CollPlant Company Information
 Table 91. CollPlant Description and Business Overview
 Table 92. CollPlant Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CollPlant Recombinant Collagen Medical Aesthetic Injection Product
 Table 94. CollPlant Recent Developments/Updates
 Table 95. Giant Biogene Holding Co., Ltd Company Information
 Table 96. Giant Biogene Holding Co., Ltd Description and Business Overview
 Table 97. Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product
 Table 99. Giant Biogene Holding Co., Ltd Recent Developments/Updates
 Table 100. Jinbo Bio Company Information
 Table 101. Jinbo Bio Description and Business Overview
 Table 102. Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Product
 Table 104. Jinbo Bio Recent Developments/Updates
 Table 105. Shuangmei Biotechnology Co., Ltd Company Information
 Table 106. Shuangmei Biotechnology Co., Ltd Description and Business Overview
 Table 107. Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product
 Table 109. Shuangmei Biotechnology Co., Ltd Recent Developments/Updates
 Table 110. Bloomage Bio Company Information
 Table 111. Bloomage Bio Description and Business Overview
 Table 112. Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Product
 Table 114. Bloomage Bio Recent Developments/Updates
 Table 115. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Company Information
 Table 116. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Description and Business Overview
 Table 117. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Product
 Table 119. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Recombinant Collagen Medical Aesthetic Injection Distributors List
 Table 123. Recombinant Collagen Medical Aesthetic Injection Customers List
 Table 124. Recombinant Collagen Medical Aesthetic Injection Market Trends
 Table 125. Recombinant Collagen Medical Aesthetic Injection Market Drivers
 Table 126. Recombinant Collagen Medical Aesthetic Injection Market Challenges
 Table 127. Recombinant Collagen Medical Aesthetic Injection Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Collagen Medical Aesthetic Injection
 Figure 2. Global Recombinant Collagen Medical Aesthetic Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Collagen Medical Aesthetic Injection Market Share by Type: 2024 & 2031
 Figure 4. Plant-derived Collagen Product Picture
 Figure 5. Animal-derived Collagen Product Picture
 Figure 6. Global Recombinant Collagen Medical Aesthetic Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant Collagen Medical Aesthetic Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Beauty Agency
 Figure 10. Global Recombinant Collagen Medical Aesthetic Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Recombinant Collagen Medical Aesthetic Injection Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Recombinant Collagen Medical Aesthetic Injection Sales (2020-2031) & (K Units)
 Figure 13. Global Recombinant Collagen Medical Aesthetic Injection Average Price (US$/Unit) & (2020-2031)
 Figure 14. Recombinant Collagen Medical Aesthetic Injection Report Years Considered
 Figure 15. Recombinant Collagen Medical Aesthetic Injection Sales Share by Manufacturers in 2024
 Figure 16. Global Recombinant Collagen Medical Aesthetic Injection Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Recombinant Collagen Medical Aesthetic Injection Players: Market Share by Revenue in Recombinant Collagen Medical Aesthetic Injection in 2024
 Figure 18. Recombinant Collagen Medical Aesthetic Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Recombinant Collagen Medical Aesthetic Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Country (2020-2031)
 Figure 21. North America Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Country (2020-2031)
 Figure 22. United States Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Country (2020-2031)
 Figure 25. Europe Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Region (2020-2031)
 Figure 33. China Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Colombia Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Recombinant Collagen Medical Aesthetic Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Recombinant Collagen Medical Aesthetic Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Recombinant Collagen Medical Aesthetic Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Recombinant Collagen Medical Aesthetic Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Recombinant Collagen Medical Aesthetic Injection by Type (2020-2031)
 Figure 53. Global Recombinant Collagen Medical Aesthetic Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Recombinant Collagen Medical Aesthetic Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Recombinant Collagen Medical Aesthetic Injection by Application (2020-2031)
 Figure 56. Global Recombinant Collagen Medical Aesthetic Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Recombinant Collagen Medical Aesthetic Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart